Drug Manufacturer Education Grants To Purchasers May Be Kickback, IG Says
Executive Summary
Education and research grants to purchasers from pharmaceutical manufacturers may violate the anti-kickback statute, the HHS Inspector General's compliance guide contends
You may also be interested in...
Drug Promotion Ban At Annual Medical Meetings Urged By Public Citizen
Pharmaceutical promotional activities at professional society annual conventions should be banned, Public Citizen declares in a study published in the recent issue of the Journal of Public Health Policy
Drug Promotion Ban At Annual Medical Meetings Urged By Public Citizen
Pharmaceutical promotional activities at professional society annual conventions should be banned, Public Citizen declares in a study published in the recent issue of the Journal of Public Health Policy
Primary Care Rx Market Offers Second-Rate Return On Investment – Bristol
Pharmaceutical companies marketing primary care products are unlikely to see a significant return on their investment, Bristol-Myers Squibb CFO Andrew Bonfield declared June 10